Chronos Therapeutics Limited

Chronos Therapeutics is focused on drug development through discovery and repositioning FDA/EMA approved drugs

Location: Oxford

Sector: Pharmaceutical

Date appointed: October 2014


Services Provided:

Chronos Therapeutics is focused on novel drug discovery and rapid drug development. Proprietary positions in the regulation of cellular chronological lifespan allows Chronos’ research to be advanced into pre-clinical stages of development for age-related diseases quickly and efficiently.

Mark Donaldson was appointed as Finance Director in October 2014, providing financial oversight, budgeting, management accounts and forecasting.

Leave a Reply